CTMX - CytomX teams up with Merck for CX-801 clinical study
2024-05-07 16:52:00 ET
More on CytomX
- CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
- CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town
- CytomX Therapeutics, Inc. (CTMX) Q4 2023 Earnings Call Transcript
- CytomX raised to buy at Jefferies in anticipation of phase 1 solid tumors asset data
- CytomX surges on upcoming data for Amgen-partnered cancer drug